Mayo, Shadieya T.
HRN: 15-82-93 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/24/2022
AZITHROMYCIN 500MG TABLET (TAB)
11/24/2022
11/29/2022
ORAL
500mg
Q24
T/C CAP MR S/P NSVD
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes